Ads
related to: biologics
Search results
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note
Zacks via Yahoo Finance· 14 hours agoAdma Biologics (ADMA) ended the recent trading session at $6.27, demonstrating a +1.13% swing from...
BioArctic and Eisai sign research evaluation agreement regarding BAN2802
FOX 8 Cleveland· 40 minutes agoBioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that BioArctic AB and Eisai Co.,...
ADMA Biologics, Inc. (NASDAQ:ADMA) Sees Significant Decline in Short Interest
ETF DAILY NEWS· 5 days agoADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) was the target of a large decline in short interest in March. As of March 31st, there was short interest totalling 7,290,000 ...
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks via Yahoo Finance· 3 days agoIn the latest trading session, Adma Biologics (ADMA) closed at $6.04, marking a -1.95% move from the...
Mirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate...
PR.com· 2 days agoWesley Chapel, FL, April 18, 2024 --(PR.com)-- Mirror Biologics, Inc., a clinical stage biopharmaceutical company announces the appointment of Elizabeth Adkins Czerepak as ...
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
Zacks via Yahoo Finance· 4 days agoJohnson & Johnson price-consensus-eps-surprise-chart | Johnson & Johnson Quote Some better-ranked...
Innovent Announces the Appointment of Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer...
FOX 59 Indianapolis· 5 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Potential Price Increase for Adma Biologics Inc
Knox Daily· 5 days agoIn a filing, Adma Biologics Inc revealed its Director ELMS STEVE unloaded Company’s shares for reported $2.5 million on Mar 19 ’24. In the deal valued at $6.08 per share,411,829 ...
Orrick Recruits Life Sciences Head From Kramer Levin in New York
Bloomberg Law· 5 days agoIrena Royzman has joined the life sciences team at Orrick Herrington & Sutcliffe in New York, the firm said Monday. Royzman’s experience includes litigation under the Hatch-Waxman Act and < ...
ADC Therapeutics Accelerates R&D with Genedata Biologics
PRWeb· 4 days agoSince then, ADC Therapeutics has diversified their product portfolio to include alternative formats and linker-payload technology. This expansion of technologies and growth of research capabilities ...
